DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-72.17%
US · US
What price implies
At 59.34 USD, the model implies roughly -0.8% annual FCF growth for 10 years, with operating margin near 33.5% and terminal growth around 3.0%. This module is a research reference.
10-year Reverse DCF scenario
Five-year annual median
From current model assumptions
Estimated from current sector rules
Each row shows a model output range, with a vertical line for the current price.
Different models rely on different financial facts. The status blocks show which lenses fit this page data.
| Model | Fit | Context |
|---|---|---|
| DCF | Suitable | Useful when recurring free cash flow history exists; sensitive to growth and discount assumptions. |
| Owner Earnings | Suitable | Useful when net income is positive and broadly tracks owner earnings. |
| Reverse DCF | Suitable | Shows the FCF growth implied by current price under stated assumptions. |
| Earnings Power Value | Suitable | Useful for mature operating profit, with limited emphasis on growth. |
| Graham Number | Limited | Works best when EPS and book value are both positive. |
| Dividend Discount Model | Not meaningful | Needs explicit dividend history, which is not part of this M1 snapshot. |
| Net-Net Liquidation Value | Not meaningful | Requires current asset and liability detail beyond the M1 static export. |
| PEG | Limited | A quick growth multiple lens when EPS history is positive. |
| EV/EBITDA | Limited | Useful for capital structure context when operating profit is available. |
| P/FCF | Limited | A compact free-cash-flow multiple view for positive FCF years. |
| P/B | Limited | More useful for asset-heavy balance sheets than asset-light companies. |
| P/S | Limited | A revenue multiple lens when profit or FCF is not stable. |
| Peer Comparison | Not meaningful | Peer set normalization is not included in the current static export. |
Hover each model row to inspect formulas and inputs.
+42.54%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-72.17%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
+133%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly -0.8% annualized FCF growth.
Estimates earnings power value without assuming growth.
+99.93%
Updated: 2026/04/29 15:27
Annual financial metrics with switchable views. · Unit: USD
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Asset impairment | Impairment | -40M USD | Medium |
| 2025/12/31 | Asset sale gain/loss | Asset sale gain/loss | 25M USD | Medium |
| 2025/12/31 | Litigation settlement | Litigation | -146M USD | Medium |
| 2024/12/31 | Asset impairment | Impairment | -154M USD | Medium |
| 2024/12/31 | Asset sale gain/loss | Asset sale gain/loss | 1B USD | Medium |
| 2024/12/31 | Litigation settlement | Litigation | -26M USD | Medium |
| 2023/12/31 | Asset impairment | Impairment | -273M USD | Medium |
| 2023/12/31 | Asset sale gain/loss | Asset sale gain/loss | -41M USD | Medium |
| 2023/12/31 | Litigation settlement | Litigation | -22M USD | Medium |
| 2022/12/31 | Asset impairment | Impairment | -913M USD | Medium |
| 2022/12/31 | Asset sale gain/loss | Asset sale gain/loss | 20M USD | Medium |
| 2022/12/31 | Litigation settlement | Litigation | -72M USD | Medium |
| 2021/12/31 | Asset impairment | Impairment | -919M USD | Medium |
| 2021/12/31 | Asset sale gain/loss | Asset sale gain/loss | 33M USD | Medium |
| 2021/12/31 | Litigation settlement | Litigation | -16M USD | Medium |
| 2020/12/31 | Asset impairment | Impairment | -1B USD | Medium |
| 2020/12/31 | Asset sale gain/loss | Asset sale gain/loss | -80M USD | Medium |
| 2020/12/31 | Litigation settlement | Litigation | -36M USD | Medium |
| 2026/03/31 | Asset sale gain/loss | Asset sale gain/loss | 20K USD | Medium |
| 2025/09/30 | Asset impairment | Impairment | -7M USD | Medium |
| 2025/09/30 | Asset sale gain/loss | Asset sale gain/loss | 6M USD | Medium |
| 2025/06/30 | Asset impairment | Impairment | -5M USD | Medium |
| 2025/06/30 | Asset sale gain/loss | Asset sale gain/loss | -5M USD | Medium |
| 2025/03/31 | Asset impairment | Impairment | -2M USD | Medium |
| 2025/03/31 | Asset sale gain/loss | Asset sale gain/loss | -365K USD | Medium |
| 2024/09/30 | Asset impairment | Impairment | -47M USD | Medium |
| 2024/09/30 | Asset sale gain/loss | Asset sale gain/loss | 474M USD | Medium |
| 2024/06/30 | Asset impairment | Impairment | -37M USD | Medium |
| 2024/06/30 | Asset sale gain/loss | Asset sale gain/loss | 1B USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 9B USD | 2B USD | 2B USD | 3B USD | 3.31 | 3.57 |
| 2024/12/31 | Annual | 5B USD | 231M USD | -797M USD | 573M USD | 0.45 | -1.56 |
| 2023/12/31 | Annual | 7B USD | 2B USD | 2B USD | 1B USD | 4.22 | 5.04 |
| 2022/12/31 | Annual | 7B USD | 2B USD | 3B USD | 2B USD | 4.38 | 6.77 |
| 2021/12/31 | Annual | 3B USD | -1B USD | -254M USD | 607M USD | -3.58 | -0.79 |
Open to inspect field-level SEC EDGAR source, filing form, and derived notes.
Quick notes on price-implied expectations, model differences, and source data.
TickerVal uses current price, estimated shares, free cash flow, and discount assumptions to infer the operating scenario embedded in market price.
Reverse DCF is not a forecast. It solves the FCF growth rate implied by current price under stated discount-rate and terminal-growth assumptions.
Each model relies on different financial facts such as cash flow, profit, assets, or revenue, so model fit and output ranges can differ.
Pages prioritize SEC EDGAR company filings, with field-level source, filing form, and derived notes shown in Source & Quality.
No. TickerVal provides research references and transparent assumptions, not personalized investment opinions.
Early supporter list
Join the research reference list for product updates, model notes, and transparent assumption workflows.
TickerVal is a research workspace, not a financial advisor. Pages on this site do not provide investment, legal, or tax advice and do not contain buy, sell, hold, ratings, price targets, or personalized recommendations. Financial data is derived from public company filings available through SEC EDGAR. TickerVal independently normalizes and computes valuation assumptions; figures may differ from company reports or other providers. TickerVal is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.
Total revenue recognized in each fiscal year.